Literature DB >> 28765045

Androgen-responsive circular RNA circSMARCA5 is up-regulated and promotes cell proliferation in prostate cancer.

Zhe Kong1, Xuechao Wan1, Yalong Zhang1, Pu Zhang1, Yingyi Zhang2, Xiaona Zhang3, Xiaoxiang Qi3, Hai Wu1, Jianfeng Huang4, Yao Li5.   

Abstract

Prostate cancer (PCa) is one of the most commonly diagnosed cancers in males worldwide. Circular RNA (circRNA) is a unique class of RNA transcribed by RNA polymerase II characterized by jointing 3' and 5' ends together via exon or intron circularization. However, the molecular functions of circRNAs in prostate cancer have rarely been explored. In present study, we found circ-SMARCA5 was up-regulated in prostate cancer samples compared to match normal tissues. We also observed circ-SMARCA5 expression was significantly induced after DHT treatment. Functional experiments showed circ-SMARCA5 acted as an oncogene in prostate cancer by promoting cell cycle and inhibiting cell apoptosis. We thought this study provided useful information for exploring circRNAs as potential therapeutic and prognostic targets for prostate cancer.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Androgen-responsive; Proliferation; Prostate cancer; circRNA; circSMARCA5

Mesh:

Substances:

Year:  2017        PMID: 28765045     DOI: 10.1016/j.bbrc.2017.07.162

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  66 in total

1.  Novel circular RNA circNF1 acts as a molecular sponge, promoting gastric cancer by absorbing miR-16.

Authors:  Zhe Wang; Ke Ma; Steffie Pitts; Yulan Cheng; Xi Liu; Xiquan Ke; Samuel Kovaka; Hassan Ashktorab; Duane T Smoot; Michael Schatz; Zhirong Wang; Stephen J Meltzer
Journal:  Endocr Relat Cancer       Date:  2019-03       Impact factor: 5.678

Review 2.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

Review 3.  Functional role of circular RNAs in cancer development and progression.

Authors:  Wei Lun Ng; Taznim Begam Mohd Mohidin; Kirti Shukla
Journal:  RNA Biol       Date:  2018-08-04       Impact factor: 4.652

4.  Analysis of pig transcriptomes suggests a global regulation mechanism enabling temporary bursts of circular RNAs.

Authors:  Annie Robic; Thomas Faraut; Sarah Djebali; Rosemarie Weikard; Katia Feve; Sarah Maman; Christa Kuehn
Journal:  RNA Biol       Date:  2019-06-03       Impact factor: 4.652

5.  Downregulation of circ-TRPS1 suppressed prostatic cancer prognoses by regulating miR-124-3p/EZH2 axis-mediated stemness.

Authors:  Jianjun Sha; Lei Xia; Qing Han; Chenfei Chi; Yinjie Zhu; Jiahua Pan; Yiran Huang; Weiliang Xia; Baijun Dong; Wei Xue; Chen Yang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

6.  Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis.

Authors:  Ming-Ming Jiang; Zhi-Tao Mai; Shan-Zhi Wan; Yu-Min Chi; Xin Zhang; Bao-Hua Sun; Qing-Guo Di
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-25       Impact factor: 4.553

Review 7.  circRNAs in Cancer.

Authors:  Ines Lucia Patop; Sebastian Kadener
Journal:  Curr Opin Genet Dev       Date:  2017-12-12       Impact factor: 5.578

8.  Analysis of the circular RNA transcriptome in the grade 3 endometrial cancer.

Authors:  Fei Ye; Qiong Lan Tang; Fang Ma; Lei Cai; Ming Chen; Xiao Xia Ran; Xiao Yu Wang; Xue Feng Jiang
Journal:  Cancer Manag Res       Date:  2019-07-05       Impact factor: 3.989

9.  Circular RNA SMARCA5 functions as an anti-tumor candidate in colon cancer by sponging microRNA-552.

Authors:  Shiwei Yang; Shanyu Gao; Tongming Liu; Junning Liu; Xia Zheng; Zhi Li
Journal:  Cell Cycle       Date:  2021-03-22       Impact factor: 4.534

10.  circSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma.

Authors:  Le Tang; Wei Xiong; Lishen Zhang; Dan Wang; Yian Wang; Yingfen Wu; Fang Wei; Yongzhen Mo; Xiangchan Hou; Lei Shi; Fang Xiong; Shanshan Zhang; Zhaojian Gong; Qianjin Liao; Bo Xiang; Wenling Zhang; Ming Zhou; Xiaoling Li; Guiyuan Li; Can Guo; Zhaoyang Zeng
Journal:  Oncogene       Date:  2020-10-29       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.